News

3 Reasons to Sell CORT and 1 Stock to Buy Instead

Corcept currently trades at $58.76 and has been a dream stock for shareholders. It’s returned 434% since March 2020, blowing past the S&P 500’s 117% gain. The company has also beaten the index over the past six months as its stock price is up 35.8%.

Trading Day: 'Tariff Man' flexes muscles, markets cower

It was really only a matter when, not if, tariff fears cast a pall over Wall Street and global markets again, and so it proved on Wednesday as investors braced for U.S. President Donald Trump's latest announcement on auto tariffs. Earlier, British finance minister Rachel Reeves delivered an update on the country's fiscal and economic health, and as I will explore below, it's a challenging outlook for sterling and UK bonds. Tech is the worst-performing sector inthe S&P 500, losing 2.5%, and with tariff and inflation fearsflaring up, consumer cyclicals lose 1.7%.

Jefferies Profit Drops on Pullback in Deals, Capital Markets

(Bloomberg) -- Jefferies Financial Group Inc.’s fiscal first-quarter earnings declined amid a drop in investment-banking and capital-markets revenue, with activity hurt by uncertainty around US policy and geopolitics. Most Read from BloombergThey Built a Secret Apartment in a Mall. Now the Mall Is Dying.Why Did the Government Declare War on My Adorable Tiny Truck?How SUVs Are Making Traffic WorseTrump Slashed International Aid. Geneva Is Feeling the Impact.Paris Votes to Make 500 More Streets Ca

Concentrix’s (NASDAQ:CNXC) Q1 Earnings Results: Revenue In Line With Expectations, Stock Soars

Customer experience solutions provider Concentrix (NASDAQ:CNXC) met Wall Street’s revenue expectations in Q1 CY2025, but sales fell by 1.3% year on year to $2.37 billion. The company expects next quarter’s revenue to be around $2.38 billion, coming in 0.6% above analysts’ estimates. Its non-GAAP profit of $2.79 per share was 7.8% above analysts’ consensus estimates.